Hans Christopher Toll
Director of Finance/CFO at KAROLINSKA DEVELOPMENT AB
Hans Christopher Toll active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KAROLINSKA DEVELOPMENT AB | Director of Finance/CFO | 30/09/2022 | - |
Umecrine Cognition AB
 Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Director of Finance/CFO | 31/12/2020 | - |
Career history of Hans Christopher Toll
Former positions of Hans Christopher Toll
| Companies | Position | Start | End |
|---|---|---|---|
| QUIAPEG PHARMACEUTICALS HOLDING AB | Director of Finance/CFO | - | - |
| AIK FOTBOLL AB | Director of Finance/CFO | - | - |
Training of Hans Christopher Toll
| Stockholm School of Economics | Masters Business Admin |
Statistics
International
| Sweden | 6 |
Operational
| Director of Finance/CFO | 4 |
| Masters Business Admin | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| KAROLINSKA DEVELOPMENT AB | Finance |
| AIK FOTBOLL AB | Consumer Services |
| QUIAPEG PHARMACEUTICALS HOLDING AB | Health Technology |
| Private companies | 1 |
|---|---|
Umecrine Cognition AB
Umecrine Cognition AB Pharmaceuticals: MajorHealth Technology Umecrine Cognition AB develops pharmaceuticals against neurological disorders in the central nervous system. The firm focuses on the development and commercialization of novel therapeutics to treat Hepatic Encephalopathy in patients with liver disease. The company was founded by Torbjörn Bäckström in 2006 and is headquartered in Solna, Sweden. | Health Technology |
